Ehab M. Gedawy

Design, synthesis, anticancer evaluation, and molecular modelling studies of novel tolmetin derivatives as potential VEGFR-2 inhibitors and apoptosis inducers

Asmaa E. Kassab, Ehab M. Gedawy, Ahmed S. Doghish et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2021 · 105 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Design, synthesis and biological evaluation of novel pyrazole sulfonamide derivatives as dual COX-2/5-LOX inhibitors

Ehab M. Gedawy, Asmaa E. Kassab, Ahmed M. El Kerdawy · European Journal of Medicinal Chemistry · 2020 · 83 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity

Asmaa E. Kassab, Ehab M. Gedawy · European Journal of Medicinal Chemistry · 2018 · 80 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Novel thienopyrimidine derivatives as dual EGFR and VEGFR-2 inhibitors: design, synthesis, anticancer activity and effect on cell cycle profile

Aml E.-S. Mghwary, Ehab M. Gedawy, Aliaa M. Kamal et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2019 · 68 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Synthesis and anticancer activity of novel 2-pyridyl hexahyrocyclooctathieno[2,3-d]pyrimidine derivatives

Asmaa E. Kassab, Ehab M. Gedawy · European Journal of Medicinal Chemistry · 2013 · 51 citations

Pharmacy, Chemistry, Medicinal Chemistry +12